Structured evidence table for Ashwagandha Cognition Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Ashwagandha Cognition Randomized Trial | Methodological quality and risk of bias were assessed with RoB 2, evidence certainty for each outcome was evaluated with GRADE system, and botanical reporting was assessed with the ConPhyMP checklist. | 1 | Zhu X (2026) | Effects of <i>Withania somnifera (L.) Dunal</i> (Ashwagandha) on cognitive and physical function in adults: a systematic review and meta-analysis. |
| Ashwagandha Cognition Randomized Trial | Ashwagandha significantly improved memory (SMD = 0.52; 95% CI: 0.27-0.78; P 2 = 29.7%), attention and processing speed (SMD = 0.29; 95% CI: 0.07-0.51; P = 0.009; I 2 = 0%), and executive function (SMD = -0.42; 95% CI: -0.70 to -0.13; P = 0.004; I 2 = 37.5%). | 1 | Zhu X (2026) | Effects of <i>Withania somnifera (L.) Dunal</i> (Ashwagandha) on cognitive and physical function in adults: a systematic review and meta-analysis. |
| Ashwagandha Cognition Randomized Trial | Visuospatial ability improved after excluding one heterogeneous study (SMD = 0.39; 95% CI: 0.08-0.70; P = 0.013; I 2 = 0%). | 1 | Zhu X (2026) | Effects of <i>Withania somnifera (L.) Dunal</i> (Ashwagandha) on cognitive and physical function in adults: a systematic review and meta-analysis. |
| Ashwagandha Cognition Randomized Trial | Background This study aimed to systematically review and evaluate the effects of Withania somnifera (L.) Dunal (Solanaceae) supplementation on cognitive and physical function in adults by meta-analysis. | 1 | Zhu X (2026) | Effects of <i>Withania somnifera (L.) Dunal</i> (Ashwagandha) on cognitive and physical function in adults: a systematic review and meta-analysis. |
| Ashwagandha Cognition Randomized Trial | The various products based oncan be found in herbalists or directly in natural-remedies specialised shops, at variable prices. | 1 | Marchi Mattia (2025) | The effect of Withania somnifera (Ashwagandha) on mental health symptoms in individuals with mental disorders: systematic review and meta-analysis |
| Ashwagandha Cognition Randomized Trial | Withania somnifera Withania somnifera Withania somnifera Withania somnifera Withania somnifera Withania somnifera Withania somnifera Withania somnifera 6 7 , 8 8 9 , 1 10 , 11 14 – 4 15 4 16 17 , 18 20 – According to available evidence, theroot extract appears to be practically non-toxic. | 1 | Marchi Mattia (2025) | The effect of Withania somnifera (Ashwagandha) on mental health symptoms in individuals with mental disorders: systematic review and meta-analysis |
| Ashwagandha Cognition Randomized Trial | By providing a comprehensive summary of the existing evidence, our study aims to provide valuable insights to potentially inform future research and advance mental health treatment options. | 1 | Marchi Mattia (2025) | The effect of Withania somnifera (Ashwagandha) on mental health symptoms in individuals with mental disorders: systematic review and meta-analysis |
| Ashwagandha Cognition Randomized Trial | Withania somnifera Solanaceae’ 1 is a perennial herbaceous plant, belonging to the ‘family and native to the Indian areas, which then spread also to Eastern Asia, Southern and Northern Equatorial Africa and Southern-Central Europe. | 1 | Marchi Mattia (2025) | The effect of Withania somnifera (Ashwagandha) on mental health symptoms in individuals with mental disorders: systematic review and meta-analysis |
Source documents